Tianjin Pharmaceutical Da Ren Tang Group Bilan de santé
Santé financière contrôle des critères 5/6
Tianjin Pharmaceutical Da Ren Tang Group has a total shareholder equity of CN¥6.5B and total debt of CN¥1.3B, which brings its debt-to-equity ratio to 19.8%. Its total assets and total liabilities are CN¥11.0B and CN¥4.5B respectively. Tianjin Pharmaceutical Da Ren Tang Group's EBIT is CN¥845.9M making its interest coverage ratio -3.2. It has cash and short-term investments of CN¥1.5B.
Informations clés
19.8%
Ratio d'endettement
CN¥1.28b
Dette
| Ratio de couverture des intérêts | -3.2x |
| Argent liquide | CN¥1.45b |
| Fonds propres | CN¥6.45b |
| Total du passif | CN¥4.52b |
| Total des actifs | CN¥10.97b |
Mises à jour récentes de la santé financière
Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Has A Rock Solid Balance Sheet
Jul 05
Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Has A Rock Solid Balance Sheet
Mar 18Recent updates
Are Investors Undervaluing Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329) By 48%?
Oct 27Why Investors Shouldn't Be Surprised By Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's (SHSE:600329) 36% Share Price Surge
Oct 08Some Shareholders Feeling Restless Over Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's (SHSE:600329) P/E Ratio
Jul 26Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Has A Rock Solid Balance Sheet
Jul 05Fewer Investors Than Expected Jumping On Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329)
Apr 18Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Has A Rock Solid Balance Sheet
Mar 18Analyse de la situation financière
Passif à court terme: 600329's short term assets (CN¥7.1B) exceed its short term liabilities (CN¥4.2B).
Passif à long terme: 600329's short term assets (CN¥7.1B) exceed its long term liabilities (CN¥323.7M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 600329 has more cash than its total debt.
Réduire la dette: 600329's debt to equity ratio has increased from 1.5% to 19.8% over the past 5 years.
Couverture de la dette: 600329's debt is well covered by operating cash flow (91.8%).
Couverture des intérêts: 600329 earns more interest than it pays, so coverage of interest payments is not a concern.